《新英格兰医药杂志》.2005年.第25期

　

• Protective Conditioning for Acute Graft-versus-Host Disease
• Management of Acute Coronary Syndromes
• Immunosuppression, Skin Cancer, and Ultraviolet A Radiation
• Professional Behavior — A Learner's Permit for Licensure
• Glycemic Control and Cardiovascular Disease — Should We Reassess Clinical Goals?
• Medical Management of Kidney Transplantation
• Cancer of the Skin
• Radiologic–Pathologic Correlations from Head to Toe: Understanding the Manifestations of Disease
• Treatment of Survivors after the Tsunami
• Boxed Warning Added to Promethazine Labeling for Pediatric Use
• Blast Injuries
• Torcetrapib and Atorvastatin — Should Marketing Drive the Research Agenda?
• Morphine, Gabapentin, or Their Combination for Neuropathic Pain
• Cardiovascular Risk Associated with Celecoxib
• Addition of Clopidogrel to Aspirin and Fibrinolytic Therapy for Myocardial Infarction
• How Ebola Virus Infects Cells
• Type 1 Diabetes — Does Suppressing T Cells Increase Insulin?
• Adjuvant Chemotherapy for Non–Small-Cell Lung Cancer — The Smoke Clears
• Sudden Death after Myocardial Infarction — Who Needs Prophylaxis, and When?
• Case 19-2005 — A 17-Year-Old Girl with Respiratory Distress and Hemiparesis after Surviving a Tsunami
• Tsunami Sinusitis
• Case 39-2005 — A 63-Year-Old Woman with a Positive Serologic Test for Syphilis and Persistent Eosinophilia
• Eye Worm
• Gastric Dilatation Secondary to Diabetic Autonomic Neuropathy
• Inhaled Nitric Oxide Therapy in Adults
• Disciplinary Action by Medical Boards and Prior Behavior in Medical School
• Oseltamivir Resistance during Treatment of Influenza A(H5N1) Infection
• Mixed Cryoglobulinemia
• Vertebrobasilar Disease
• Peginterferon Alfa-2b and Ribavirin for 12 vs. 24 Weeks in HCV Genotype 2 or 3
• Insulin Needs after CD3-Antibody Therapy in New-Onset Type 1 Diabetes
• Vinorelbine plus Cisplatin vs. Observation in Resected Non–Small-Cell Lung Cancer
• Sudden Death in Patients with Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or Both
• Tailoring Arthritis Therapy in the Wake of the NSAID Crisis
• The Lessons of Vioxx — Drug Safety and Sales
• American Bioethics: Crossing Human Rights and Health Law Boundaries
• The Run on Tamiflu — Should Physicians Prescribe on Demand?
• Oseltamivir Resistance — Disabling Our Influenza Defenses
• The Year of Magical Thinking
• Ending Life: Ethics and the Way We Die
• Lesser Harms: The Morality of Risk in Medical Research
• Imatinib and Hyperlipidemia
• Academic–Industrial Relationships
• Primary Biliary Cirrhosis
• Effector Memory T Cells, Early Metastasis, and Survival in Colorectal Cancer
• Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes
• Tumor-Infiltrating T Cells — Friend or Foe of Neoplastic Cells?
• Safety of Long-Acting Beta-Agonists — An Urgent Need to Clear the Air